After-Hours ER Care May Come With A Doctor’s Surcharge
Patients sometimes find an additional charge, generally between $30 and $200, tacked onto their bill for visiting a hospital emergency room between 10 p.m. and 8 a.m.
Health Industry
2,721-2,740 of 4,027 results
-
-
The Throwaway Scope: A Way To Ditch Superbugs?
Small manufacturers are betting that disposable medical scopes will slash the risk of infection during procedures. Some doctors are skeptical of the cheaper models.
By Chad Terhune -
Without ACA Guarantees, 52 Million Adults Could Have Trouble Buying Individual Plans
More than a quarter of adults under the age of 65 have health problems that could lead to a denial of insurance if they were on the individual market and the health lawās protections were revoked under the overhaul planned by Republicans, according to research by the Kaiser Family Foundation.
-
Price Poised To Protect Doctors’ Interests At HHS
As a Republican congressman, orthopedic surgeon Tom Price introduced bills to protect doctorsā financial interests.
By Christina Jewett and Marisa Taylor -
Grab Bag Of Goodies In 21st Century Cures Act
A breakdown of winners ā and a few losers ā in the sprawling Cures Act approved by the House.
By Sydney Lupkin and Steven Findlay -
Senate Approves Landmark Mental Health Bill As Part Of 21st Century Cures Act
The U.S. Senate passed a landmark bill to help millions of Americans suffering from mental illness.
By Liz Szabo -
California Tests Electronic Database For End-Of-Life Wishes
San Diego and Contra Costa counties are piloting a registry so emergency responders can know quickly how much treatment patients want.
By Anna Gorman -
Doctors And Hospitals Say āShow Me The Moneyā Before Treating Patients
As patientsā share of medical bills has grown with the rise in deductibles, copays and coinsurance, providers have become laser focused on getting payments up front.
-
Insurersā Flawed Directories Leave Patients Scrambling For In-Network Doctors
Many consumers find that doctors listed in their planās directories arenāt accepting new patients, charge large concierge fees or may not even be in the network. Regulators donāt check.
By Jay Hancock -
Deadly Infections Linked To Heart Surgery Device Highlight Holes In FDA Monitoring
The federal agency took 14 months to warn the public about the potential for infections. Officials say they acted as fast as they could.
By Chad Terhune and Christina Jewett -
A Frenzy Of Lobbying On 21st Century Cures
Three lobbyists for every member of Congress in a push to pass a bill that increases research funding and speeds up approvals.
-
Long-Stalled FDA Reform Sits On Senateās Lame-Duck Calendar
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patientsā safety and doesnāt do enough to stop spiraling drug prices.
-
Uncertain Fate Of Health Law Giving Health Industry Heartburn
The effect of ārepeal and replaceā could have greatest consequences for hospitals. They accepted lower federal funding under the law because their uncompensated care was expected to fall as more people became insured.
By Julie Rovner and Chad Terhune -
Victims Seek Payments As ‘Dr. Death’ Declares Innocence
While hundreds of his former patients submit claims for restitution, a Detroit cancer doctor convicted of making millions by purposefully poisoning them with drugs they didnāt need vows to prove his innocence.
-
Study Finds Nearby Retail Clinics Donāt Drive Down ER Visits
The results suggest that retail clinics may not provide a solution for reducing unnecessary emergency department visits, researchers say.
-
A Consumerās Guide To Medicareās New Rules On Doctor Pay
Federal officials have released final regulations for the new program, which will reward physicians for providing high quality, efficient care.
-
Medical Device Employees Are Often In The O.R., Raising Concerns About Influence
The āreps,ā who are there to answer any technical questions that arise during surgery, also often cultivate close relationships with the doctors, leading to questions about how much influence they wield.
-
‘Durable Cure’ Is Goal For Childhood Cancer, But Recent Patients Have Persistent Issues
People treated in the 1990s report worse health problems later in life than those treated in the two previous decades.
-
Bad Hombres, Russian Hackers And ā¦ A Medical Device Tax?
Why an obscure revenue raiser for the Affordable Care Act has found its way into a number of congressional campaign ads.
-
FDAās Drug Approval Team Copes With 700 Unfilled Jobs As Industry Lures Staff
The FDAās drug-approval team is short more than 700 people and losing skilled staff members to the drug industry.
By Sydney Lupkin and Sarah Jane Tribble